Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma
Programmed cell death-ligand 1 (PD-L1) expression has been shown to play important roles in various types of cancer. However, the role of PD-L1 expression has not been conclusively reported in patients with oral squamous cell carcinoma (OSCC). Accordingly, in this meta-analysis, we investigated the...
Main Authors: | Cui Yong-Xin, Su Xian-Shuang |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-04-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/med.2020.15.issue-1/med-2020-0041/med-2020-0041.xml?format=INT |
Similar Items
-
Prognostic Function of Programmed Cell Death-Ligand 1 in Esophageal Squamous Cell Carcinoma Patients Without Preoperative Therapy: A Systematic Review and Meta-Analysis
by: Hongxia Cui, et al.
Published: (2021-08-01) -
Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis
by: Jing-Hua Li, et al.
Published: (2018-09-01) -
Serum alkaline phosphatase in oral squamous cell carcinoma and its association with clinicopathological characteristics
by: Swetha Acharya, et al.
Published: (2017-01-01) -
Characteristics of Microbial Distribution in Different Oral Niches of Oral Squamous Cell Carcinoma
by: Fujiao Nie, et al.
Published: (2022-08-01) -
Programmed Cell Death Ligand 1 Immunoexpression in Head and Neck Squamous Cell Carcinoma: A Narrative Review of Considerations for the Histopathologist
by: Pooja Sharma Kala, et al.
Published: (2024-02-01)